Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs

Yang, Wenying; ERSOY, CANAN; Wang, Guixia; Ye, Shandong; Liu, Jun; Miao, Heng; Asirvatham, Arthur; Werther, Shanti; Kadu, Priti; Chow, Francis

doi:10.1016/j.diabres.2019.02.023

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs

Copy For Citation

Yang W., ERSOY C., Wang G., Ye S., Liu J., Miao H., ...More

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.150, pp.158-166, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 150
Publication Date: 2019
Doi Number: 10.1016/j.diabres.2019.02.023
Journal Name: DIABETES RESEARCH AND CLINICAL PRACTICE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.158-166
Bursa Uludag University Affiliated: Yes

Abstract

Aims: To compare the efficacy and safety of biphasic insulin aspart 30 (BIAsp 30) administered three times daily (TID) vs. twice daily (BID), plus metformin, in patients with type 2 diabetes mellitus (T2DM) inadequately controlled on basal insulin +/- 1 oral antidiabetic drug (OAD).